» Articles » PMID: 6131823

Nifedipine in the Treatment of Difficult Hypertensives

Overview
Specialty Pharmacology
Date 1983 Jan 1
PMID 6131823
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Nifedipine has been assessed as a possible alternative to other third line drugs in the management of patients with difficult to control hypertension. A group of 20 patients whose blood pressure was unsatisfactory on a 3 drug regimen had their third drug stopped and after a 2 week period nifedipine was added to their beta-blocker plus diuretic therapy. Eleven became normotensive on 30 mg nifedipine daily and a further 6 on 60 mg daily; giving on overall success rate of 85%. This result was achieved with a reduction in side effects and an absence of any haemodynamic or metabolic complications.

Citing Articles

Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol.

Kendall M, JACK D, Laugher S, Lobo J, Rolf Smith S Br J Clin Pharmacol. 1984; 18(3):331-5.

PMID: 6487472 PMC: 1463644. DOI: 10.1111/j.1365-2125.1984.tb02472.x.


Role of nifedipine in treatment of hypertension.

Murphy M, Scriven A, Dollery C Br Med J (Clin Res Ed). 1983; 287(6387):257-9.

PMID: 6409272 PMC: 1548889. DOI: 10.1136/bmj.287.6387.257.


Effects of BAY l 5240, a fixed combination of low dose nifedipine and acebutolol on hypertension: comparison with standard dose nifedipine.

Lejeune P, Gunselmann W, Hennies L, Hess K, Rittgerodt K, Winn K Eur J Clin Pharmacol. 1985; 28(1):17-21.

PMID: 3886399 DOI: 10.1007/BF00635702.


The intra- and inter-subject variability of nifedipine pharmacokinetics in young volunteers.

Lobo J, JACK D, Kendall M Eur J Clin Pharmacol. 1986; 30(1):57-60.

PMID: 3709633 DOI: 10.1007/BF00614196.


The management of hypertension.

Prichard B, OWENS C Br J Clin Pharmacol. 1986; 21 Suppl 2:129S-142S.

PMID: 3530297 PMC: 1400731. DOI: 10.1111/j.1365-2125.1986.tb02862.x.


References
1.
JACK D, Dean S, Kendall M . Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography. Five commonly used beta blockers and hydralazine. J Chromatogr. 1980; 187(1):277-80. DOI: 10.1016/s0021-9673(00)87901-7. View

2.
Olivari M, BARTORELLI C, Polese A, Fiorentini C, Moruzzi P, Guazzi M . Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation. 1979; 59(5):1056-62. DOI: 10.1161/01.cir.59.5.1056. View

3.
Husserl F, Messerli F . Adverse effects of antihypertensive drugs. Drugs. 1981; 22(3):188-210. DOI: 10.2165/00003495-198122030-00002. View

4.
Aoki K, Kondo S, Mochizuki A, Yoshida T, Kato S, Kato K . Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J. 1978; 96(2):218-26. DOI: 10.1016/0002-8703(78)90089-3. View

5.
BARTORELLI C, Magrini F, Moruzzi P, Olivari M, Polese A, Fiorentini C . Haemodynamic effects of a calcium antagonistic agent (nifedipine) in hypertension: therapeutic implications. Clin Sci Mol Med Suppl. 1978; 4:291s-292s. DOI: 10.1042/cs055291s. View